The effect of membrane exposure on lateral ridge augmentation: a case-controlled study by Eskan, Mehmet A. et al.
RESEARCH Open Access
The effect of membrane exposure on
lateral ridge augmentation: a case-
controlled study
Mehmet A. Eskan1,5*, Marie-Eve Girouard2, Dean Morton3 and Henry Greenwell4
Abstract
Background: The effect of membrane exposure on guided bone regeneration (GBR) for lateral ridge augmentation
has been poorly addressed. This case-controlled study aimed to investigate potential effect of membrane exposure
lateral ridge augmentation and subsequent implant placement.
Methods: A total of 14 patients that did receive lateral ridge augmentation procedure using allogeneic cancellous
graft particulate in combination with an alloplastic bioresorbable matrix barrier were retrospectively selected for this
study. Bone width was measured at the crest with a digital caliper before bone augmentation and at the reopening
for implant placement 4 months later for all patients. Cases where primary flap closure was achieved and the
barrier did not expose throughout the time until implant placement were assigned to the control group (n = 7).
Cases where primary closure could not be achieved or a barrier exposure happened within the first week following
the initial surgery were assigned to the test group.
Results: The measured alveolar ridge width before surgery as well as after GBR procedure were not statistically
significant different between the two groups (p > 0.05). Both groups showed a significant (p < 0.05) increase in their
mean alveolar ridge width 4 months after later augmentation procedure, from 3.4 ± 1.2 to 6.0 ± 1.1 mm in the
control group and from 3.6 ± 1.0 to 5.0 ± 1.4 mm in the test group. However, the mean alveolar ridge gain was
significantly greater in the control group than in the test group (p < 0.05). Consequently, the reduction of the
augmented alveolar ridge was significantly higher in the test group averaging to 4.7 mm than for the control
group showing a loss of 3.1 mm after 4 months, respectively. However, in all 14 cases, successful implant
placement was achieved after 4 months.
Conclusions: Within the limit of this study, it can be concluded that early exposure of a bioresorbable matrix
barrier during lateral ridge augmentation may compromise the results of the GBR procedure but may still result in a
favorable alveolar ridge width gain that allows for the placement of dental implants.
Keywords: Graft loss, Lateral ridge augmentation, Matrix barrier, Membrane exposure
Background
It has been reported that unpreserved alveolar ridges
can show substantial horizontal and/or vertical ridge de-
ficiency [1, 2] that lack the sufficient alveolar ridge di-
mensions to allow the ideal positioning of the implant
and enhance long-term prognosis of the clinical out-
comes [3]. Guided bone regeneration (GBR) is a
predictable technique for augmenting the alveolar ridge
width that has been used for more than two decades,
and osseointegration and long-term implant survival rate
have been reported to be similar in grafted areas than in
native bone [4, 5].
One of the main components in GBR procedures is the
use of a resorbable or non-resorbable barrier membranes
that stabilize the bone grafting material and protect it
from the ingrowth of surrounding soft tissues [6, 7].
Therefore, non-resorbable PTFE membranes have been
developed for GBR that present an inner occlusive surface
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to prevent migration of epithelial and fibroblast cells into
the defect and to maintain adequate space for bone forma-
tion and wound stabilization [8]. However, PTFE mem-
brane might lead to compromised vascular supply of the
flaps [9] and exhibited a higher incidence of premature
membrane exposures [8, 10, 11] as well as gingival reces-
sion [12], which might cause an esthetic problems in the
anterior regions.
It is well know that primary closure is increasing the
clinical outcome of the GBR procedures [6]. To over-
come membrane exposure, it has been suggested to per-
form a periosteal releasing incision [13]. However,
periosteal releasing incisions might cause more swelling,
bleeding, and patient discomfort. Importantly, they also
may compromise blood circulation [14], and re-
positioning flap coronally can result in a misaligned
mucogingival line (MGL) if not properly performed [13].
This misaligned MGL might also cause esthetic prob-
lems especially in the anterior regions. Therefore, the
use of resorbable membrane in the patients might be
beneficial, especially in patients with thin soft tissue
biotypes.
Various resorbable membranes exist in the market com-
posing of dura mater, poly-lactic acid, polyglycolic acid,
polyurethane, or mostly collagen. Still, even resorbable
membranes show frequent events of membrane exposures
after GBR procedures. For example, between 22 and 32%
of early membrane exposure have been reported for colla-
gen membrane by several authors [15–18]. A major draw-
back of collagen membrane might be that lose their
integrity in 1 week [18] when exposed to the proteolytic
environment of the oral cavity that leaves the graft mater-
ial unprotected and can lead to graft loss.
Alloplastic barriers have been proposed as dental
membranes for regenerative dentistry that show slower
degradation but still good biocompatibility [19–21].
Among those, bioresorbable matrix barrier has been de-
veloped for periodontal regeneration and showed effect-
iveness to reduce epithelial down-growth while
promoting the formation of periodontal ligament and al-
veolar bone in various clinical studies [19, 22–25]. How-
ever, the documentation of the performance of
bioesorbable matrix barrier in GBR procedures is spares
[26–29] and their performance in the case of matrix ex-
posure remains elusive.
Therefore, this case-controlled study aims to investi-
gate the effectiveness of GUIDOR bioresorbable matrix
barrier for lateral bone augmentation procedures and
the effect of exposures on its performance.
Methods
Fourteen subjects were retrospectively recruited for this
case-controlled study. In test group (seven patients), pri-
mary closure was not achieved and membrane was left
exposed at the initial surgery or it became exposed dur-
ing the first week of healing. In the control group (seven
patients), primary wound closure was achieved and no
exposure of the membrane occurred until the placement
of a dental implant 4 months after augmentation. Each
patient received a particulate cancellous allograft (500 to
800 μm, RegenerOss, BioMet 3i), and then, the grafted
defect area was covered with a bioresorbable matrix
membrane (Sunstar, Suisse SA, Etoy, Switzerland). Lon-
ger span edentulous spaces were divided into individual
sites based on a 10–12-mm width per site, and each site
was bordered by at least one tooth. The subject inclu-
sion criteria included a treatment that was planned to
receive a dental implant in the future. At least 18-year-
old males and females were included in this study. All
subjects signed an informed consent approved by the
University of Louisville Institutional Review Board in
July 2010. Exclusion criteria excluded patients with un-
controlled diabetes, who are smokers, and with immune
diseases or other systemic diseases that significantly
affect the periodontium; patients with an allergy to any
material or medication used in this study; and patients
who need prophylactic antibiotics, previous head and
neck radiation therapy, and chemotherapy in the previ-
ous 12 months and with severe psychological problems.
Surgical treatment
All surgical procedures were done by one surgeon (ME).
The surgical procedure consisted of the reflection of a
full thickness flap to expose the residual alveolar ridge.
Following complete exposure of the defect area, horizon-
tal ridge width was measured with a digital caliper at the
midridge crestal level. Horizontal ridge measurements
(at the crestal level) included initial ridge, initial aug-
mented ridge (residual ridge plus graft), and the ridge at
the re-entry after the 4-month healing time. All mea-
surements were performed by a masked examiner
(MEG), who was unaware of the treatments. Cortical
perforations were performed with a ½ round bur to in-
crease vascularization in the defect area [30]. The bone
screws (Salvin Dental Specialties, Charlotte, NC) and
cancellous particulate allograft were placed to allow for
augmentation to achieve 8 mm horizontal width avail-
able for implant placement. Horizontal measurements
were again taken with the same caliper. Then, the
grafted area was covered with a bioresorbable matrix
barrier. In the buccal surface, the graft material was
completely covered by the membrane. However, in the
lingual or palatal surface, the membrane was tucked
least 5 mm between the alveolar bone and gingival tis-
sue. Periosteal releasing incisions were performed when
needed, and all wound was tried to close primarily and
flap re-positioned coronally without compromising
MGL. In the test group, the membrane could not be
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closed primarily (Fig. 1a) or became exposed to the oral
environment in 1 week after primary closure was
achieved during surgery (Fig. 1b). In the control group,
primary closure was achieved with a monofilament su-
ture (Cytoplast, PTFE Suture, Osteogenics Biomedical,
Lubbock, TX) (Fig. 1c). The patients were prescribed
doxycycline hyclate 50 mg once a day for 2 weeks and
hydrocodone when needed. Sutures were removed in
10 days. The subjects were seen every other week to
clean the area with hydrogen peroxide.
Statistical analysis
Means ± SD was calculated for all parameters. The stat-
istical significance difference of means between the
groups was tested using an exact two-sample Fisher-
Pitman permutation test; since the sample size seemed
too small to test for normality, p < 0.05 was considered
to be significant.
Results
The effect of early membrane exposure on alveolar ridge
width changes
To assess if the baseline situations of the patients in the
two treatment groups were comparable and well bal-
anced, the distribution of gender, age, and the initial
ridge measurements were compared. There were three
women and four men in each group. The median age for
the test and control group was 50 and 62 years old, re-
spectively (Table 1). The initial alveolar mean ridge
widths before lateral augmentation in the test and con-
trol group were 3.6 ± 1.0 and 3.4 ± 1.2 mm, respectively
(Table 2). Therefore, the baseline situation of the two
groups was comparable (p > 0.05).
No infection, discomfort, or suppuration was reported
for neither of the two groups throughout the study, and
all surgical sites did heal uneventfully. The initial mean
ridge width before lateral augmentation of the control
group increased from 3.4 ± 1.2 to 6.0 ± 1.1 mm at the 4-
month re-entry (Table 2). The initial mean ridge width
before lateral augmentation increased from 3.6 ± 1.0 to
5.0 ± 1.4 mm at the 4-month re-entry in the test group
(Table 2). This led to an alveolar mean ridge gain of 1.4
± 1.0 mm in the test group and 2.6 ± 1.0 mm in the con-
trol group. Both groups did show a statistically signifi-
cant (p < 0.05) ridge width gain between baseline and at
the 4-month re-entry (Table 2). However, the results
showed that early exposure (test group) resulted in sig-
nificant (p < 0.05) less gain of the alveolar ridge width
than when the membrane was not exposed (Table 2).
The effect of early membrane exposure on graft
reduction
Furthermore, the reduction of the augmented ridge
width right after the lateral augmentation (baseline) to
implant placement (after 4 months) was assessed in each
subjects. The mean ridge width after lateral ridge aug-
mentation procedure was 9.7 ± 0.9 mm for the test
group and 9.1 ± 0.8 mm for the control group (Table 3).
The difference between the groups were not statically
significant (Table 3). Therefore, baseline situations of the
two groups were comparable. Regardless the membrane
exposure, there was a significant (p > 0.05) reduction of
Fig. 1 Clinical photographs of the both treatment groups after the
initial surgery, 1 week post-op and at the re-entry. a) In the test group,
no primary wound closure was achieved (left) and the barrier was
left exposed for secondary intention healing. After 1 week, the
matrix remained exposed (middle) showing no signs of infection.
For months later, the exposed area was covered by a keratinized
tissue (right). b) In the test group, primary wound closure was
achieved at surgery (left). However, the barrier became exposed
after 1 week of healing (middle). For months later, exposed area
was covered with a keratinized tissue (right). c) In the control
group, primary wound closure was achieved (left). After 1 week
(middle), primary healing happened without any signs of membrane
exposure. For months later, the site healed uneventfully (right)
Table 1 Patient population and demographics and sites
Groups Subject no. Sex Site Age
Exposed (test) group 1 Female 13 74
2 Male 6 62
3 Female 29 62
4 Male 12 62
5 Male 8 59
6 Male 19 29
7 Female 9 23
Non-exposed (control) group 8 Female 11 60
9 Female 30 68
10 Male 30 68
11 Male 9 50
12 Male 25 42
13 Female 10 39
14 Male 9 25
In the control (non-membrane exposure) and test group (membrane
exposure), the subject’s age, sex, and defect areas are presented
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the initial later ridge augmentation in the both groups
after the 4-month healing time. However, the augmented
ridge width reduction of 4.7 ± 1.4 mm in the test group
was significantly higher (p < 0.05) than the 3.1 ± 0.9 mm
assessed for the control group (Table 3). The percentage
of ridge width reduction was 48 ± 13% in the test group
compared to 33 ± 10% in the control group. Therefore,
early membrane exposure resulted in higher reduction
of the augmented ridge.
Discussion
Although numerous studies in the literature show suc-
cessful outcomes of the GBR procedure [6, 31], the most
common clinical complication in GBR procedures is
early membrane exposure [9]. There is a general clinical
impression that the ridge augmentation results are
compromised in the case of early membrane exposures
[32, 33]. In this case-controlled study, which was based
on a patient subset from our previous randomized clin-
ical trial, the clinical effect of exposure of a bioresorba-
ble matrix membrane was evaluated [27]. Based on
clinical ridge width dimension measurements, a mean
ridge width gain of 1.4 and 2.6 mm were calculated for
the test and the control group, respectively. On the
other hand, a reduction of 4.7 and 3.1 mm of the initially
augmented ridge width was measured for the test and
control group, respectively. Together, these results
clearly indicated that the early membrane exposure in
lateral ridge augmentation procedure resulted in signifi-
cantly lower ridge width gain probably due to a signifi-
cant higher resorption of the augmented graft during the
healing process.
Still, the ridge width gain in both groups was sufficient to
allow for the successful placement of dental implants in all
14 subjects without any complication. The exposed matrix
barrier degraded within 6–7 weeks or was covered by soft
tissue without any further complications. This observed
degradation time is markedly longer than that of collagen
membrane, which is reported to be completely resorbed 1
to 2 weeks after exposure [18, 34]. The prolonged degrad-
ation time of matrix barrier seems to provide prolonged
protecting of the underlying graft supporting the bone re-
generation process. During this healing process, all expo-
sures did resolve within 6–7 weeks and no membrane had
to be extracted. During this period, the exposed bioresorba-
ble matrix barrier became covered with keratinized tissue
over time. The secondary healing in exposed area lead to a
subsequent increase in the width of keratinized tissue su-
perior to the band of keratinized tissue observed in the
control group (Fig. 1a). This shows the epithelization nor
the subsequent keratinization process was not altered by an
inflammatory situation that could have been triggered by
the presence of the matrix barrier or its degradation prod-
uct. This demonstrated the good healing properties of this
barrier membrane. However, the gain of keratinized tissue
was not quantitatively measured; thus, this is a clinical ob-
servation rather than a documented outcome. The predict-
ability of gaining both keratinized tissue and horizontal
ridge dimension simultaneously needs further investigation
to confirm this observation. The other main advantage
using a bioresorbable matrix barrier over non-resorbable
PTFE membrane in the GBR procedures was that all expo-
sures did resolve within 6–7 weeks without any complica-
tions and without the need of second surgery to extract the
barrier. This might be an important advantage in the
Table 2 Baseline and re-entry measurement of the alveolar ridge width
Groups Initial ridge width (mm) Ridge width at re-entry (mm) Ridge width gain (mm)
Exposed (tests) 3.6 ± 1.0 5.0 ± 1.4 1.4 ± 1.0
Non-exposed (control) 3.4 ± 1.2 6.0 ± 1.1 2.6 ± 1.0
Fisher-Pitman permutation p = 1.00 p = 0.168 p = 0.047
At the entry and re-entry, the alveolar ridge width was measured using a digital caliper at the crestal level in both groups. In the control group (non-exposure),
the mean ridge width was 3.4 mm and changed to 6.0 mm (p < 0.01). In the test group, the mean of ridge was 3.6 mm and changed to 5.0 mm. p values that
were calculated for between mean groups analysis are displayed. Alveolar ridge gain was calculated by subtracting re-entry measurement from the entry
measurement for each patient at the crestal level using a digital caliper. In the control group, the mean of the gain was 2.6 mm, while it was 1.4 mm in
the test group. p values for between-groups analysis are displayed
Table 3 Alveolar ridge width reduction
Groups Grafted ridge width Ridge width at the re-entry Grafted ridge reduction (mm)
Exposed (test) 9.7 ± 0.9 5.0 ± 1.4 4.7 ± 1.4
Non-exposed (control) 9.1 ± 0.8 6.0 ± 1.1 3.1 ± 0.9
Fisher-Pitman p = 1.00 p = 0.260 p = 0.030
The residual alveolar ridge width plus graft width was measured at the crestal level at the entry and re-entry procedure. In the test and control group, the mean
of the grafted width was 9.7 and 9.1 mm, respectively. Graft reduction was 4.7 and 3.1 mm for the test and control group, respectively. The percentage of the
graft reduction was calculated using the formula: ([Amount of graft reduction/Grafted alveolar bone width] × 100. p values for between-groups analysis
are displayed
Eskan et al. International Journal of Implant Dentistry  (2017) 3:26 Page 4 of 6
patient showing a thin biotype and in situations where pri-
mary closure is difficult to achieve in the GBR procedures.
The microbial contamination of the matrix barrier dur-
ing exposure could be another important factor that might
hamper bone formation within the underlying graft. This
factor has not been investigated in the present study.
However, it has been reported by other groups that the re-
sorbable matrix barrier per se might be less prone to bac-
terial contamination and can be better cleaned using
disinfectant agents such as chlorhexidine rinse than PTFE
membranes [35]. Matrix membrane presents an outer and
inner surface. The external surface is more occlusive (the
pore sizes are bigger than those of internal surface) to
allow gingival tissue penetration. The internal layer,
smaller pores, prevents further penetration of the gingival
tissue through the barrier, thus protecting new bone for-
mation underneath the barrier. From clinical observation,
the space between the two layers seemed already occupied
by connective tissue protecting the inner layer and leaving
only the outer layer of the matrix exposed to the oral cav-
ity and subsequent degradation. Still, this clinical observa-
tion has to be confirmed in further studies.
The results from this study suggest that primary flap
closure over the matrix barrier is preferable leading to bet-
ter ridge width gain than when the matrix is left exposed
or early exposures happen. However, exposures were not
completely detrimental to the lateral ridge augmentation
and sufficient ridge width gain could be achieved allowing
for successful implant placement. In critical cases, where 1
or 2 mm less bone would affect the esthetic results, the
matrix barrier should not be left exposed and due care
should be taken to avoid any exposures during healing
after primary closure was achieved.
Conclusions
Within the limits of this case-controlled study, it can be
concluded that lateral ridge augmentation procedures in
atrophic alveolar ridges using bioresorbable matrix bar-
riers without achieving primary flap closure or in the
case of early exposures can still lead to clinically satisfy-
ing ridge width gain that allows for the placement of
dental implants. However, exposures seem to limit the
ridge width gain. Therefore, in esthetic challenging situa-
tions, efforts should be made to achieve primary wound
closure and to avoid subsequent membrane exposure.
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